BHPW
Beverly Hills Private Wealth’s Novo Nordisk NVO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.1M | Buy |
44,882
+1,679
| +4% | +$116K | 0.58% | 48 |
|
|
2025
Q1 | $3M | Buy |
43,203
+7,048
| +19% | +$489K | 0.59% | 45 |
|
|
2024
Q4 | $3.11M | Buy |
36,155
+6,200
| +21% | +$533K | 0.63% | 37 |
|
|
2024
Q3 | $3.57M | Buy |
29,955
+5,307
| +22% | +$632K | 0.72% | 30 |
|
|
2024
Q2 | $3.52M | Buy |
24,648
+4,083
| +20% | +$583K | 0.76% | 30 |
|
|
2024
Q1 | $2.64M | Buy |
20,565
+4,601
| +29% | +$591K | 0.61% | 40 |
|
|
2023
Q4 | $1.65M | Buy |
15,964
+3,325
| +26% | +$344K | 0.43% | 71 |
|
|
2023
Q3 | $1.15M | Buy |
12,639
+3,847
| +44% | +$350K | 0.34% | 76 |
|
|
2023
Q2 | $1.38M | Buy |
8,792
+2,766
| +46% | +$433K | 0.23% | 103 |
|
|
2023
Q1 | $959K | Buy |
6,026
+2,238
| +59% | +$356K | 0.3% | 86 |
|
|
2022
Q4 | $513K | Buy |
+3,788
| New | +$513K | 0.22% | 109 |
|